Last month we were delighted to join our friends at the Mid Ulster Clinic in Magherafelt for an exclusive event on Sperm DNA Damage and male fertility featuring our very special guest Mr Jonathan Ramsay. “I think male fertility is moving on, and it’s time to move with it and the first stage is DNA… Read more »
In December 2023 we received such wonderful news as little Leon was welcomed into the world. Leon’s parents provide a detailed account from the moment they knew there were fertility issues, to how they approached these, and to receiving a successful outcome following a challenging 3 years. We were delighted to have helped play a… Read more »
Examen has announced the appointment of Paul Holroyd as Chief Commercial Officer in a move that marks an exciting stage of expansion for the company. With more than 30 years’ experience in cutting edge technology businesses from start-ups to public limited companies, Paul has worked with global businesses at both board and management level to… Read more »
Belfast, Northern Ireland, 4th March 2022 / Examen, leaders in male fertility research and diagnostics, is delighted to announce that semen analysis is now available at its Belfast facility. This comes in response to unprecedented demand for fertility services as couples continue to face delays in accessing appointments owing to the backlog caused by the pandemic. Examen’s semen analysis test… Read more »
We recently passed our ISO 13485:2016 accreditation! This seal of approval from the BSI shows our quality management system satisfies the requirements of ISO 13485:2016 and EN ISO 13485:2016 for the design, development and manufacture of in vitro diagnostic DNA-based assays for sperm cell analysis. The high quality of our Exact sperm DNA tests is… Read more »
Examen has received two Invest NI Grants for Research and Development, supporting company innovation in services, products and processes. Part financed by the Investment for Growth and Jobs Programme 2014 – 2020 after for Northern Ireland co financed by the European Regional Development Fund. The projects are: Project 1: To develop a home production kit… Read more »
New study reveals Sperm DNA damage is a key indicator of the likelihood of miscarriage Belfast, UK, 26th October 2020 / A new study demonstrates that sperm DNA damage, measured by Exact® tests using an alkaline Comet assay, acts as a reliable biomarker for sporadic and recurrent miscarriage in both spontaneous and assisted conception. The study, published in Reproductive… Read more »
Eileen Regan joins Examen as Chief Commercial Officer as the company expands to meet the needs of the UK’s top fertility clinics Belfast, Northern Ireland, 21st September 2020: Examen, a world leader in male fertility testing, announces the expansion of its senior management team, with the appointment of Eileen Regan who joins as Chief Commercial Officer…. Read more »
